{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:01:12Z","timestamp":1761742872556},"reference-count":59,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.gyobfe.2006.09.015","type":"journal-article","created":{"date-parts":[[2006,11,8]],"date-time":"2006-11-08T12:34:18Z","timestamp":1162989258000},"page":"1015-1023","source":"Crossref","is-referenced-by-count":16,"title":["Dispositif intra-ut\u00e9rin au\u00a0l\u00e9vonorgestrel (Mirena\u00ae) et\u00a0cancer du\u00a0sein: que nous apporte la\u00a0litt\u00e9rature pour\u00a0la\u00a0pratique quotidienne?"],"prefix":"10.1016","volume":"34","author":[{"given":"G.","family":"Boutet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.gyobfe.2006.09.015_bib1","first-page":"4","article-title":"Qui? Combien? Tentative de description d\u00e9mographique de la population concern\u00e9e","volume":"29","author":"Est\u00e8ve","year":"2005","journal-title":"Lett. S\u00e9nol"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0039-128X(00)00177-X","article-title":"The levonorgestrel intrauterine system: therapeutic aspects","volume":"65","author":"Luukkainen","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib3","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2165\/00002018-200427150-00003","article-title":"Benefit-risk assessment of the levonorgestrel intrauterine system in contraception","volume":"27","author":"Backman","year":"2004","journal-title":"Drug Saf."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib4","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0010-7824(91)90078-T","article-title":"An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDS","volume":"44","author":"Chi","year":"1991","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1783\/147118904322995474","article-title":"The levonorgestrel-releasing intrauterine system (LNG-IUS) in contraception and reproductive health","volume":"30","year":"2004","journal-title":"J. Fam. Plann. Reprod. Health Care"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib6","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1471-0528.2000.tb11610.x","article-title":"Levonorgestrel-releasing (20\u00a0microgram\/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives","volume":"107","author":"French","year":"2000","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.gyobfe.2006.09.015_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001776.pub2","article-title":"Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy","author":"French","year":"2004","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib8","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/jama.291.12.1456","article-title":"Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomised trial 5-year follow-up","volume":"291","author":"Hurskainen","year":"2004","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.gyobfe.2006.09.015_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002126.pub2","article-title":"Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding","author":"Lethabi","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ebobgyn.2004.12.008","article-title":"Levonorgestrel-releasing intrauterine system for menorrhagia cost less than hysterectomy over 5\u00a0years","volume":"7","author":"Myers","year":"2005","journal-title":"Evidence-based Obstet. Gynecol."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/s-2001-18644","article-title":"Therapeutic use of the LNG IUS, and counselling","volume":"19","author":"Pakarinen","year":"2001","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2165\/00002018-199615060-00006","article-title":"A risk-benefit assessment of the levonorgestrel-releasing intrauterine system","volume":"15","author":"Sturridge","year":"1996","journal-title":"Drug Saf."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib13","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.gyobfe.2006.06.019","article-title":"Efficacit\u00e9 et tol\u00e9rance du syst\u00e8me intra-ut\u00e9rin au l\u00e9vonorgestrel dans la prise en charge des m\u00e9norragies fonctionnelles: \u00e9tude fran\u00e7aise multicentrique","volume":"34","author":"Yaszbek","year":"2006","journal-title":"Gynecol. Obstet. Fertil."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1471-0528.2002.01167.x","article-title":"Intrauterine 10 and 20\u00a0\u00b5g levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response","volume":"109","author":"Raudaskoski","year":"2002","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib15","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0015-0282(16)57365-8","article-title":"Intrauterine and subdermal progestin administration in postmenopausal hormone replacement therapy","volume":"63","author":"Suhonen","year":"1995","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.maturitas.2004.08.008","article-title":"Continuous combined parenteral estrogen substitution and intrauterine progestogen delivery: the ideal HST combination?","volume":"51","author":"Wildemeersch","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0010-7824(78)90029-X","article-title":"Sustained intrauterine release of d-norgestrel","volume":"18","author":"Luukkainen","year":"1978","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0010-7824(80)90003-7","article-title":"Levonorgestrel plasma concentrations and hormone profiles after insertion and after one year of treatment with a levonorgestrel-IUD","volume":"21","author":"Nilsson","year":"1980","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib19","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0015-0282(16)49397-0","article-title":"Sustained intrauterine release of levonorgestrel over five years","volume":"45","author":"Nilsson","year":"1986","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/07853899009147248","article-title":"Levonorgestrel-releasing intrauterine device","volume":"22","author":"Luukkainen","year":"1990","journal-title":"Ann. Med."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0010-7824(90)90035-T","article-title":"Pharmacokinetic and pharmacodynamic studies of levonorgestrel-releasing intrauterine device","volume":"41","author":"Bilian","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib22","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.fertnstert.2004.07.961","article-title":"Serum and peritoneal fluid levels of levonorgestrel in women with endometriosis who were treated with an intrauterine contraceptive device containing levonorgestrel","volume":"83","author":"Lockhat","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0010-7824(95)00102-G","article-title":"Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use","volume":"51","author":"Bilian","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0010-7824(76)90007-X","article-title":"Plasma levels of d-norgestrel after oral administration","volume":"14","author":"Weiner","year":"1976","journal-title":"Contraception"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0002-9378(77)90741-4","article-title":"d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing women","volume":"129","author":"Nilsson","year":"1977","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib26","series-title":"Sein, hormones et antihormones, 26es Journ\u00e9es de la Soci\u00e9t\u00e9 fran\u00e7aise de s\u00e9nologie et de pathologie mammaire","first-page":"396","article-title":"La contraception chez les femmes ayant un ant\u00e9c\u00e9dent de cancer du sein","author":"Andr\u00e9","year":"2004"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib27","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/01.AOG.0000178754.88912.b9","article-title":"Use of the levonorgestrel-releasing intrauterine system and breast cancer","volume":"106","author":"Backman","year":"2005","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib28","unstructured":"Tr\u00e9tarre B. Sein. In: Remontet L ed. \u00c9volution de l\u2019incidence et de la mortalit\u00e9 par cancer en France de 1978 \u00e0 2000. Paris: Institut de veille sanitaire; 2003. p. 99\u2013105. R\u00e9f\u00e9rence consultable sous format \u00e9lectronique: URL: http:\/\/www.invs.sante.fr."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib29","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.gyobfe.2003.07.006","article-title":"Tamoxif\u00e8ne, cancer de l'endom\u00e8tre et dispositif intra-ut\u00e9rin au levonorgestrel","volume":"31","author":"Espi\u00e9","year":"2003","journal-title":"Gynecol. Obstet. Fertil."},{"issue":"suppl 3","key":"10.1016\/j.gyobfe.2006.09.015_bib30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/humrep\/15.suppl_3.162","article-title":"Morphological and functional changes in human endometrium following intrauterine levonorgestrel delivery","volume":"15","author":"Jones","year":"2000","journal-title":"Hum. Reprod."},{"issue":"suppl 3","key":"10.1016\/j.gyobfe.2006.09.015_bib31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/humrep\/15.suppl_3.173","article-title":"Insulin-like growth factors and insulin-like growth factor binding proteins in the endometrium. Effect of intrauterine levonorgestrel delivery","volume":"15","author":"Rutanen","year":"2000","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib32","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S1297-9589(02)00486-1","article-title":"Effets sur l\u2019endom\u00e8tre des oestrog\u00e8nes et des anti-estrog\u00e8nes","volume":"30","author":"Bergeron","year":"2002","journal-title":"Gynecol. Obstet. Fertil."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib33","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0029-7844(99)00660-2","article-title":"Modulation of endometrial steroid receptors and growth regulatory genes by tamoxifen","volume":"95","author":"Elkas","year":"2000","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1006\/gyno.1999.5558","article-title":"Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients","volume":"75","author":"Cohen","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib35","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ygyno.2004.03.048","article-title":"Endometrial pathologies associated with postmenopausal tamoxifen treatment","volume":"94","author":"Cohen","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib36","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1200\/JCO.2005.11.050","article-title":"Adjuvant endocrine therapy for premenopausal women with early breast cancer","volume":"23","author":"Dellapasqua","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ebobgyn.2005.09.013","article-title":"Endometrial cancer risk remained elevated years after stopping tamoxifen treatment for breast cancer","volume":"7","author":"Hoogendoorn","year":"2005","journal-title":"Evidence-based Obstet. Gynecol."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/jnci\/dji057","article-title":"Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study","volume":"97","author":"Swerdlow","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0029-7844(97)00549-8","article-title":"The effects of tamoxifen on endometrial insulin-like growth factor-1 expression","volume":"91","author":"Elkas","year":"1998","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib40","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(00)03204-9","article-title":"Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial","volume":"356","author":"Gardner","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejogrb.2005.10.029","article-title":"Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS) \u2013 A systematic enquiry and overview","volume":"125","author":"Varma","year":"2006","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib42","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0140-6736(05)71222-8","article-title":"Levonorgestrel-releasing intrauterine devices","volume":"357","author":"Cohen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib43","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0140-6736(05)71223-X","article-title":"Levonorgestrel-releasing intrauterine devices","volume":"357","author":"Gerber","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib44","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/S0140-6736(00)03197-4","article-title":"Local levonorgestrel to prevent tamoxifen-related endometrial lesions","volume":"356","author":"Neven","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib45","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1525-1438.2006.00546.x","article-title":"Endometrial adenocarcinoma following insertion of the levonorgestrel-releasing intrauterine system (Mirena) in a 36-year-old woman","volume":"16","author":"Abu","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib46","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1006\/gyno.2002.6817","article-title":"Endometrial adenocarcinoma following the insertion of a Mirena IUCD","volume":"87","author":"Jones","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib47","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","article-title":"Endometrial cancer","volume":"366","author":"Amant","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(05)78091-0","article-title":"Longitudinal hysteroscopic follow-up during tamoxifen treatment","volume":"351","author":"Neven","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib49","series-title":"Sein, hormones et antihormones, 26es Journ\u00e9es de la Soci\u00e9t\u00e9 Fran\u00e7aise de S\u00e9nologie et de Pathologie Mammaire","first-page":"424","article-title":"\u00c9tude des interf\u00e9rences potentielles entre progestatifs et tamoxif\u00e8ne","author":"Neven","year":"2004"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib50","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0039-128X(01)00094-0","article-title":"Regulation of sex hormone-binding globulin secretion in human hepatoma G2 cells","volume":"66","author":"Browne-Martin","year":"2001","journal-title":"Steroids"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib51","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1046\/j.1365-2303.1998.00077.x","article-title":"Behaviour of vaginal epithelial maturation and sex hormone binding globulin in post-menopausal breast cancer patients during the first year of tamoxifen therapy","volume":"9","author":"Bertolissi","year":"1998","journal-title":"Cytopathology"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib52","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.ygyno.2004.10.031","article-title":"Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature","volume":"97","author":"Dhar","year":"2005","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib53","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/01.AOG.0000195269.76793.bb","article-title":"Use of the levonorgestrel-releasing intrauterine system and breast cancer","volume":"107","author":"Tjalma","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib54","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.maturitas.2006.03.010","article-title":"Plasma concentrations of levonorgestrel in patients with an intrauterine progestogen delivery system: do they have any significance?","volume":"55","author":"Trinh","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib55","doi-asserted-by":"crossref","unstructured":"Plu-Bureau G, Touraine P, Kuttenn F. Sein et hormones. Encycl Med Chir, Gyn\u00e9cologie 2002; 810-A-10: 1\u201319.","DOI":"10.1016\/S0246-1064(02)00071-3"},{"key":"10.1016\/j.gyobfe.2006.09.015_bib56","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/01.AOG.0000195970.65200.3e","article-title":"Reply on Tjalma WA, Trinh XB, van Dam PA. Use of the Levonorgestrel-releasing intrauterine system and breast cancer","volume":"107","author":"Backman","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib57","unstructured":"OMS. Crit\u00e8res de recevabilit\u00e9 pour l'adoption et l'utilisation continue des m\u00e9thodes contraceptives. Gen\u00e8ve: OMS; 2005. R\u00e9f\u00e9rence consultable sous format \u00e9lectronique: URL: http:\/\/who.int."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib58","unstructured":"Afssaps\u2013Anaes\u2013Inpes. Recommandations pour la pratique clinique. Strat\u00e9gies de choix des m\u00e9thodes contraceptives chez la femme. Afssaps, Anaes, Inpes: Paris; 2004. R\u00e9f\u00e9rence consultable sous format \u00e9lectronique: URL: http:\/\/afssaps.sante.fr."},{"key":"10.1016\/j.gyobfe.2006.09.015_bib59","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1701-2163(16)32196-X","volume":"28","year":"2006","journal-title":"J. Obstet. Gynaecol. Can."}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958906003730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958906003730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T06:21:38Z","timestamp":1707373298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297958906003730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S1297958906003730"],"URL":"https:\/\/doi.org\/10.1016\/j.gyobfe.2006.09.015","relation":{},"ISSN":["1297-9589"],"issn-type":[{"value":"1297-9589","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}